Statistics for Evolocumab in paediatric heterozygous familial hypercholesterolaemia cognitive function during 80 weeks of openlabel extension treatment
Total visits
views | |
---|---|
Evolocumab in paediatric heterozygous familial hypercholesterolaemia cognitive function during 80 weeks of openlabel extension treatment | 0 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |